across geography. First, medical R&D has a self-limiting effect. Contemporary innovation discourages trial participation and … slows down development necessary for future innovation. Thus, medical R&D suffers increasing costs over time, driven by …, affect the returns to innovation, not only by altering the firm's variable profits, but also by increasing the length and …

Introduction -- Industrial and science, technology and innovation (STI) policies in Japan and South Korea -- STI … policies in Japan -- STI policies in Korea -- Science, technology and innovation policies in Japan and Korea -- STI and …